Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimenJade Ghosn, Jean-François Delfraissy, Ghislaine Leleu et al.|Antiviral Therapy|2010Cited by 39